# OnCo record gilead (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gilead/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gilead" ;
  schema:name "Gilead Sciences (incl. Kite)"@en ;
  schema:description "Gilead owns Trodelvy (via the $21B Immunomedics deal) and the Kite CAR-T franchise."@en ;
  schema:url <https://onco.cc/companies/gilead/>, <https://www.gilead.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.gilead.com> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/cell-therapy/> ;
  onco:drugs <https://onco.cc/drugs/sacituzumab-govitecan/>, <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/domvanalimab/>, <https://onco.cc/drugs/quemliclustat/> ;
  onco:companies <https://onco.cc/companies/arcellx/>, <https://onco.cc/companies/tmunity-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct05089734/>, <https://onco.cc/trials/nct06801834/>, <https://onco.cc/trials/nct06413498/>, <https://onco.cc/trials/nct06486441/>, <https://onco.cc/trials/nct05371093/>, <https://onco.cc/trials/nct07527858/>, <https://onco.cc/trials/nct05633667/>, <https://onco.cc/trials/nct05676931/>, <https://onco.cc/trials/nct06253663/>, <https://onco.cc/trials/nct06727565/>, <https://onco.cc/trials/nct05186974/>, <https://onco.cc/trials/nct06926920/>, <https://onco.cc/trials/nct03547973/>, <https://onco.cc/trials/nct05840211/>, <https://onco.cc/trials/nct05119907/>, <https://onco.cc/trials/nct05609968/>, <https://onco.cc/trials/nct05329766/>, <https://onco.cc/trials/nct05101096/>, <https://onco.cc/trials/nct04454437/>, <https://onco.cc/trials/nct03964727/>, <https://onco.cc/trials/nct04639986/> .